KFDA nods ACT based wound healing therapy

Published: 2010-05-31 06:57:00
Updated: 2010-05-31 06:57:00
The Korea Food and Drug Administration said it has approved a new autologous cell therapy (ACT) developed by S. Biomedics, a local biopharmaceutical company.

Autologous material can be utilized as both a stand-alone treatment or in composite with other materials, according to a company officia...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.